New York City, July 14, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE:BETR) (OTCQB:BETRD) (FRA: BLife Therapeutics BLife TherapeuticsNPAT) indicated the...
New York City, July 06, 2020 (GLOBE NEWSWIRE) -- The CEO of BetterLife Pharma (OTCQB:BETRD) (CSE: BETR) (FRANKFURT: NPAT), an emerging clinical stage pharmaceutical development company, recently...
New York, June 30, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma (OTCQB:BETRD) (CSE: BETR) (FRANKFURT: NPAT), an emerging clinical stage pharmaceutical development company, believe that a...
New York City, June 19, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma (OTCQB:BETRF) (CSE: BETR) (FRANKFURT: NPAT), an emerging clinical stage pharmaceutical development company, announced recently...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.005 | -4.16666666667 | 0.12 | 0.12 | 0.105 | 17120 | 0.10664136 | CS |
4 | 0 | 0 | 0.115 | 0.125 | 0.105 | 13295 | 0.11315455 | CS |
12 | -0.02 | -14.8148148148 | 0.135 | 0.145 | 0.105 | 23696 | 0.11880471 | CS |
26 | 0 | 0 | 0.115 | 0.195 | 0.09 | 50100 | 0.13226795 | CS |
52 | 0.06 | 109.090909091 | 0.055 | 0.195 | 0.055 | 68283 | 0.11193206 | CS |
156 | -0.105 | -47.7272727273 | 0.22 | 0.305 | 0.05 | 79165 | 0.13204403 | CS |
260 | -0.035 | -23.3333333333 | 0.15 | 2.9 | 0.04 | 91714 | 0.32566057 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales